ono-1110
Small moleculeexperimental
Clinical trial activity
5 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
5
Phase 3
0
Phase 4
0
Earliest trial started Jan 10, 2025 (NCT06708416)
Timeline
2020s
- Jan 1, 2025
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06752590 | Phase 2 | Mar 31, 2025 | Ono Pharmaceuticals |
| NCT06752603 | Phase 2 | Mar 31, 2025 | Ono Pharmaceuticals |
| NCT06805565 | Phase 2 | Jan 31, 2025 | Ono Pharmaceuticals |
| NCT06792136 | Phase 2 | Jan 17, 2025 | Ono Pharmaceuticals |
| NCT06708416 | Phase 2 | Jan 10, 2025 | Ono Pharmaceuticals |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ono Pharmaceuticals | For profit | 5 | 5 | 1 | 2025 |
1 organizations
Page 1 / 1